These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3224951)

  • 21. A research agenda for disruptive behaviors in Alzheimer's disease: a combined biomedical and behavioral approach.
    Raskind M
    Int Psychogeriatr; 1996; 8 Suppl 1():53-8. PubMed ID: 8934266
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.
    Tariot PN; Ryan JM; Porsteinsson AP; Loy R; Schneider LS
    Clin Geriatr Med; 2001 May; 17(2):359-76. PubMed ID: 11375140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sultopride, treatment of choice for agitation in severe encephalopathies. Apropos of 33 cases in a neuropediatric milieu].
    Gadisseux JF; Fournaux J; Hallet J; Ferriere G
    Neuropsychiatr Enfance Adolesc; 1983; 31(2-3):159-64. PubMed ID: 6866222
    [No Abstract]   [Full Text] [Related]  

  • 24. Alzheimer's disease. Is it worth treating?
    Hollister LE
    Drugs; 1985 Jun; 29(6):483-8. PubMed ID: 4006773
    [No Abstract]   [Full Text] [Related]  

  • 25. What provision is made by practicing physicians for psychogeriatric patients in western Germany?
    Hornung WP; Rudolf GA
    Int Psychogeriatr; 1995; 7(1):105-14. PubMed ID: 7579014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful multimodality treatment of severe behavioral disturbance in a patient with advanced Huntington's disease.
    Blass DM; Steinberg M; Leroi I; Lyketsos CG
    Am J Psychiatry; 2001 Dec; 158(12):1966-72. PubMed ID: 11729010
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of behavior disorders in patients with dementia].
    Sival RC; Jansen PA; van Nieuwkerk JF; Klaverwijden G
    Ned Tijdschr Geneeskd; 1992 May; 136(20):967-71. PubMed ID: 1594076
    [No Abstract]   [Full Text] [Related]  

  • 28. Major uses of psychopharmacology in the emergency department.
    Glod CA
    J Emerg Nurs; 1994 Feb; 20(1):33-7; quiz 37-9. PubMed ID: 8126944
    [No Abstract]   [Full Text] [Related]  

  • 29. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.
    Selbaek G; Kirkevold Ø; Engedal K
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):528-36. PubMed ID: 18591573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atlanta case study: determining what is "special" in an Alzheimer disease special care unit.
    Wimberley ET; Kutner NG
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S115-25. PubMed ID: 8068251
    [No Abstract]   [Full Text] [Related]  

  • 31. Problems and prospects in the treatment of dementia.
    Dagon EM; Liebman A
    Wis Med J; 1982 Aug; 81(8):32-4. PubMed ID: 6753350
    [No Abstract]   [Full Text] [Related]  

  • 32. Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care.
    Gallagher D; Herrmann N
    Neurodegener Dis Manag; 2015; 5(1):75-83. PubMed ID: 25711456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological treatment of agitation in a nursing home.
    Billig N; Cohen-Mansfield J; Lipson S
    J Am Geriatr Soc; 1991 Oct; 39(10):1002-5. PubMed ID: 1680888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic management of the symptoms of dementia.
    McDonald WM; Krishnan KR
    Am Fam Physician; 1990 Jul; 42(1):123-32. PubMed ID: 2195854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use.
    Bartels SJ; Horn SD; Smout RJ; Dums AR; Flaherty E; Jones JK; Monane M; Taler GA; Voss AC
    Am J Geriatr Psychiatry; 2003; 11(2):231-8. PubMed ID: 12611753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Older patient agitation treatment].
    Cruz Jentoft AJ
    Rev Clin Esp; 2003 Jul; 203(7):346-8. PubMed ID: 12797917
    [No Abstract]   [Full Text] [Related]  

  • 37. Occupational therapy and dementia: the experience of an Alzheimer special care unit.
    Baldelli MV; Pradelli JM; Zucchi P; Martini B; Orsi F; Fabbo A
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():49-54. PubMed ID: 17317433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial.
    Lichtwarck B; Selbaek G; Kirkevold Ø; Rokstad AM; Benth JŠ; Myhre J; Nybakken S; Bergh S
    BMC Psychiatry; 2016 Jul; 16():233. PubMed ID: 27406242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principal components analysis of agitation outcomes in Alzheimer's disease.
    Yesavage JA; Taylor JL; Friedman L; Rosenberg PB; Lazzeroni LC; Leoutsakos JS; Kinoshita LM; Perlow MJ; Munro CA; Devanand DP; Drye LT; Mintzer JE; Pollock BG; Porsteinsson AP; Schneider LS; Shade DM; Weintraub D; Lyketsos CG; Noda A;
    J Psychiatr Res; 2016 Aug; 79():4-7. PubMed ID: 27115509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavior and Evolution of Young ONset Dementia part 2 (BEYOND-II) study: an intervention study aimed at improvement in the management of neuropsychiatric symptoms in institutionalized people with young onset dementia.
    van Duinen-van den IJssel JCL; Appelhof B; Zwijsen SA; Smalbrugge M; Verhey FRJ; de Vugt ME; Zuidema SU; Koopmans RTCM; Bakker C
    Int Psychogeriatr; 2018 Mar; 30(3):437-446. PubMed ID: 28595662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.